These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 202387)

  • 1. Comparative ultrastructural studies of nucleoli of tumor cells treated with adriamycin and the newer anthracyclines, carminomycin and marcellomycin.
    Daskal Y; Woodard C; Crooke ST; Busch H
    Cancer Res; 1978 Feb; 38(2):467-73. PubMed ID: 202387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute ultrastructural effects of the antitumor antibiotic carminomycin on nucleoli of rat tissues.
    Merski JA; Daskal Y; Crooke ST; Busch H
    Cancer Res; 1979 Apr; 39(4):1239-44. PubMed ID: 421207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural study of the effect of bleomycin A2 on the nucleolus and its possibly related cytoplasmic constituents in Novikoff hepatoma cells.
    Daskal Y; Crooke ST; Smetana K; Busch H
    Cancer Res; 1975 Feb; 35(2):374-81. PubMed ID: 45894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adriamycin on ultrastructure of nucleoli in the heart and liver cells of the rat.
    Merski JA; Daskal I; Busch H
    Cancer Res; 1976 May; 36(5):1580-4. PubMed ID: 1268820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adriamycin-induced nucleolar segregation in skeletal muscle, cardiac muscle, and liver cells.
    Merski J; Daskal Y; Busch H
    Cancer Treat Rep; 1978 May; 62(5):771-8. PubMed ID: 657162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of several anthracycline antitumor antibiotics on the transcriptional activity of isolated nucleoli.
    DuVernay VH; Crooke ST
    J Antibiot (Tokyo); 1980 Sep; 33(9):1048-53. PubMed ID: 6160136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface effects of adriamycin and carminomycin immobilized on cross-linked polyvinyl alcohol.
    Wingard LB; Tritton TR; Egler KA
    Cancer Res; 1985 Aug; 45(8):3529-36. PubMed ID: 4016734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.
    Wassermann K; Zwelling LA; Mullins TD; Silberman LE; Andersson BS; Bakic M; Acton EM; Newman RA
    Cancer Res; 1986 Aug; 46(8):4041-6. PubMed ID: 3731072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross resistance in tumor cells and staphylococci with respect to anthracycline-group antineoplastic antibiotics].
    Shorin VA; Averbukh LA
    Antibiotiki; 1976 Oct; 21(10):914-9. PubMed ID: 999240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural requirements for the formation of anthracycline-DNA adducts.
    Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
    Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural nucleolar alterations induced by an ametantrone/polyr(A-U) complex.
    Thiry M; Jamison JM; Gilloteaux J; Summers JL; Goessens G
    Exp Cell Res; 1997 Oct; 236(1):275-84. PubMed ID: 9344608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassembly of functional nucleoli following in situ unraveling by low-ionic-strength treatment of cultured mammalian cells.
    Zatsepina OV; Dudnic OA; Chentsov YS; Thiry M; Spring H; Trendelenburg MF
    Exp Cell Res; 1997 May; 233(1):155-68. PubMed ID: 9184085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver mono-oxygenases and the pharmacodynamics of carminomycin and rubomycin].
    Bogush TA; Sitdikova SM
    Antibiotiki; 1984 Jun; 29(6):446-50. PubMed ID: 6476808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents].
    Egorov LV; Khanykova OK; Kuznetsova TV; Gerasimova NA; Kozinets GI
    Antibiotiki; 1977 Jul; 22(7):639-43. PubMed ID: 883808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spherical bodies and fibrillar centers in hepatic cell nucleoli of rats treated with D-galactosamine.
    Mikhaylova VT; Markov DV
    Exp Cell Res; 1994 May; 212(1):10-21. PubMed ID: 8174631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
    DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
    Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of carminomycin on the energy metabolism of the liver in rats].
    Bulanova LA; Gol'dberg ED; Sal'nik BIu; Chulalina NP
    Antibiotiki; 1979 Mar; 24(3):218-24. PubMed ID: 443783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.